Stock Events

Satellos Bioscience 

€0.45
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
54.37M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

23NovConfirmed
Q3 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0.34
-0.23
-0.13
-0.02
Expected EPS
-0.07
Actual EPS
-0.05

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0ITA.F. It's not an investment recommendation.

About

Satellos Bioscience Inc., a biotechnology company, develops regenerative therapeutics to treat degenerative muscle diseases. Its lead program focuses on the discovery and development of a small molecule drug for the treatment of duchenne. The company's MyoReGenX, an automated microscopy system which recapitulates the muscle stem cell environment ex-vivo. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.
Show more...
CEO
Mr. Francis Gleeson B.B.A. M.B.A
Country
CA
ISIN
CA80401L3083
WKN
000A3CSSM

Listings